FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32610511000001100: Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99512501000001113 Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99512601000001112 Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Is a Magnesium oxide 160mg capsules 30 capsule true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Has AMP Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Has specific active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Magnesium oxide 160mg capsules (Alissa Healthcare Research Ltd) 30 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start